Researchers in South Korea have developed a groundbreaking peptide that shows potential to both prevent hair loss and regenerate hair follicles, as well as aid in the recovery of damaged skin. While hair has long held sociocultural significance, its primary biological role is protective. This new peptide may represent a major advancement in both dermatology and cosmetic science.

According to the American Hair Loss Association (AHLA), androgenetic alopecia—commonly known as male-pattern baldness—affects a large portion of the population at an early age. By age 35, approximately 23% of American men experience noticeable hair loss, with 25% beginning to lose hair as early as age 21. Importantly, hair loss is not limited to men—about 40% of individuals affected by partial hair loss are women.

In their study of hair loss and follicular biology, Professor Choi Kang-yeol and his research team discovered elevated levels of a protein called CXXC5 in the scalp areas of individuals experiencing hair loss. This protein acts as a negative regulator of the Wnt/β-catenin signaling pathway, which is critical for both hair follicle formation and wound healing.

The team found that when CXXC5 binds to another protein known as Dishevelled (Dvl), it disrupts follicle development and regeneration. To counteract this, the scientists developed a novel biochemical compound named PTD-DBM, which blocks the interaction between CXXC5 and Dishevelled. In laboratory experiments, the application of PTD-DBM to the skin of bald mice stimulated the regrowth of hair within 28 days.

The researchers also discovered that when PTD-DBM was combined with valproic acid (VPA), a known activator of the Wnt pathway, hair regrowth was even more rapid and pronounced.

Current hair loss treatments are often ineffective for individuals with complete baldness, as they primarily aim to accelerate existing hair growth rather than regenerate new follicles. Moreover, many available medications come with side effects due to their hormone-suppressing mechanisms, such as reducing testosterone levels.

The next phase of research will focus on evaluating the safety and potential toxicity of this peptide. If proven non-toxic, this treatment could offer a revolutionary non-surgical alternative to existing solutions like hair transplants.

Professor Choi emphasized that this discovery marks the identification of a key regulatory protein in hair growth, along with the development of a novel drug that modulates this pathway to promote follicle regeneration.

‍